Rothlisberger, UrsulaGossens, ChristianTavernelli, Ivano2006-02-272006-02-272006-02-272005https://infoscience.epfl.ch/handle/20.500.14299/226241WOS:000228177705654Organoruthenium compds. have emerged as promising novel anticancer agents but very little is known about their mol. mechanism of action. Here, we present classical and mixed QM/MM first-principles MD simulations of two ruthenium(II) compds. and their binding to DNA. [on SciFinder (R)]Binding of organoruthenium anticancer drugs to DNAtext::conference output::conference proceedings::conference paper